ArticleThe Analyst2026
Evaluation of ToF-SIMS imaging for semi-quantitative mapping of BODIPY-labeled fibronectin surface gradients.
Article in The Analyst, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Microfluidic platforms offer controlled microenvironments for studying cell migration such as haptotaxis. In many gradient-based assays, protein gradients are first visualized using higher concentrations of fluorescent labels, since gradients formed at biologically relevant ligand densities often fall below the detection limits of conventional imaging methods. In this study, we demonstrate the feasibility of characterizing fibronectin gradients using a more sensitive, high-resolution approach with Time-of-Flight Secondary Ion Mass Spectrometry (ToF-SIMS). Our methods increase analytical sensitivity to fibronectin gradients formed on commonly used synthetic surfaces to better elucidate physiological mechanisms and ensure experimental reproducibility. We utilized a microfluidic chip with a silicone housing placed on an optically clear plastic microscope slide designed for live-cell microscopy. Slides were coated with fibronectin incorporating surrogate labels for ToF-SIMS analysis to investigate spatial distribution. To enhance signal detection, fibronectin was labeled or conjugated with copper, bromine, and fluorine-containing BODIPY as surrogate elements. Among the tested labels, BODIPY-fibronectin (BODIPY-FN) provided the lowest background signal, enabling fluorescence-based detection at concentrations of 10 µg mL
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.